Mike Walther, President and Board member, has 30 years of expertise leading start up to established therapeutics, diagnostics and medical device businesses. Prior to joining Prometheus in 2019 following the acquisition, Mike was General Manager of Aries Pharmaceuticals, having joined this start up as an Executive team member heading up Marketing and Commercial Strategy of the company’s portfolio of 5 pharmaceutical and medical device gastroenterology products. Mike has held senior leadership roles at Prometheus Laboratories (Nestle), Takeda Pharmaceuticals and TAP Pharmaceuticals, a joint venture between Takeda and Abbott Labs. In his career Mike has brought over 35 new products and indications to market.
